Covid-19 vaccine race: US makes deal for 100 million doses

Published Aug 3, 2020


CAPE TOWN- The United States (U.S) announced over the weekend it will pay $2.1 billion to two major drug companies to produce 100 million doses of an experimental Covid-19 vaccine.

French pharmaceutical company Sanofi will receive more than half of the money to produce the vaccine candidate while Great Britain’s GlaxoSmithKline will continue to make a booster that improves how the body responds to it.